Tuesday 15 December, 14:00 – 16:30
Pharmacology in the time of COVID
|14:00||Introduction and welcome||Dr Tim Hardman,
|14:10||Burden of therapy: a novel safety assessment||Dr Ayad Abdulahad,
How we have contained Covid-19 in a dedicated clinical trials unit.
|Dr Jorg Taubel,
|15.10||Summary of MHRA preparations for BREXIT||Dr Kirsty Wydenbach,
Clinical Trials Unit, MHRA
|15.55||Partnering with the U.K. to investigate, and supply on compassionate grounds, an investigational medicine for COVID-19 in wave 1 of the pandemic.||Dr Philip Troke,
Gilead Sciences Ltd.
|16:25||Running phase 1 clinical trials during a pandemic||Radboud van Trigt and Jan Leendert Pouwel Brouwer,
PRA Health Sciences
|16.50||Discussion and closing remarks||Dr Tim Hardman,
CPD points for this meeting have been applied for.
Please contact us with any questions at firstname.lastname@example.org
We are open for sponsorship for this year’s meeting.